News – Page 883 – Endpoints News

FDA panel largely opposes expanding use of Lilly, Boehringer's SGLT2 inhibitor to type 1 diabetics

6 years ago

Bayer bets up to $100M on exploring new biomolecular condensate terrain with a biotech upstart

6 years ago

Investors could emerge from Neil Woodford debacle with £1B loss, internal analysis reveals

6 years ago

Seattle and Daiichi Sankyo at each other's throats; UC Berkeley, UCSF and the University of Washington launch Weill ...

6 years ago

FDA slaps a hold on an AML trial as Marker scraps a failing ovarian cancer program, sinking shares

6 years ago

Takeda doubles down on Finch's microbiome insights, signing up for a second project in Crohn's disease

6 years ago

GSK's asthma biologic Nucala scores in rare blood disorder study

6 years ago

FDA’s Project Orbis may expand to Singapore and Switzerland

6 years ago

Eli Lilly-backed biotech grabs $100M to dispatch antibody-oligonucleotide conjugates after muscular dystrophy

6 years ago

Ahead of FDA decision on BTK drug, Amgen-partnered BeiGene is one step closer to China OK for PD-1

6 years ago

Merck buys a fledgling neurodegenerative biotech spawned by an old GSK discovery alliance. What’s up with that?

6 years ago

AstraZeneca sets stage for marketing application with promising pivotal lupus drug data

6 years ago

Kiadis abandons lead PhIII program, shifts focus to natural killer cells

6 years ago

Merck shutters French research site in a reorganization aimed at eliminating more than 200 jobs

6 years ago

Editas and Celgene sub Juno are tackling hottest immunotherapy cells

6 years ago

Amgen axes 149 of its staff in Cambridge office; Evotec, MilliporeSigma enter research pact

6 years ago

Flagship woos Novartis top dealmaker Prakash Raman in move to get the BD ball rolling early

6 years ago

Celgene execs shell out $92M cash for a pair of R&D deals that will fit perfectly in their new home at Bristol-Myers

6 years ago

Reata's bardoxolone offers promise in patients with rare kidney disorder

6 years ago

FDA Vascepa review spotlights new safety signals, possible mineral oil spoiler as Amarin hunts a blockbuster approval

6 years ago

Kadmon waxes rhapsodic on cGVHD results as race with Jakafi heats up

6 years ago

ARCH-backed Chinese biotech scores PhIII win for glucokinase-modulating diabetes drug

6 years ago

FDA puts Solid Bio’s lead gene therapy program on hold — again — after another patient is hurt by SGT-001

6 years ago

Voters say Congress needs to curb drug prices. So why do the odds look grim for major legislation this year?

6 years ago

First page Previous page 880 881 882883884 885 886 Next page Last page